Cefuroxime (2Nd Gen) Powder For Suspension Suppliers & Bulk Manufacturers
Available Forms: Powder for Suspension
Available Strengths: 125 mg/5 mL, 250 mg/5 mL, 500 mg/5 mL
Reference Brands: Ceftin, Zinacef(US & EU)
Category:
Antibiotics
Cefuroxime suspension inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, causing bacterial lysis and death. It effectively treats respiratory, urinary, and skin infections. Benefits include easy oral administration, rapid bacterial eradication, and broad-spectrum activity, making it suitable for pediatric and outpatient use for common bacterial infections.
Cefuroxime (2nd Gen) Powder for Suspension is available in Powder for Suspension
and strengths such as 125 mg/5 mL, 250 mg/5 mL, 500 mg/5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cefuroxime (2nd Gen) Powder for Suspension is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefuroxime (2nd Gen) Powder for Suspension can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cefuroxime suspension is approved in the EU and US for treating respiratory, urinary, and skin infections. In the EU, brands like Zinacef are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers and pharmacovigilance plans for approval and ongoing safety monitoring. Due to its widespread use and safety profile, strict regulations on labeling, dosing, and usage are enforced. For expert assistance with dossier preparation, compliance, and registration, visit PharmaTradz. We support seamless market access ensuring adherence to European and American standards for effective antimicrobial therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing